NHS Cancer Plan

Oncology

The NHS Cancer Plan has commissioned the Royal College of Radiologists with a formal review of opportunities to modernise Multi-Disciplinary Teams.

R&D

Whole-genome sequencing provides an unbiased and complete view of the human genome and enables the discovery of genetic variation.

News

Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.